Biodexa Pharmaceuticals Plc (BDRX) stock
BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.04−0.10 (-4.89%)
Close on Nov 18, 2026Market cap $4.60MP/E –Yield –
Biodexa Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -£5.59M. The highest annual figure on record is -£5.59M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -£5.59M | – |
| FY2024 | Dec 31, 2024 | -£12.27M | – |
| FY2023 | Dec 31, 2023 | -£6.85M | – |
| FY2022 | Dec 31, 2022 | -£7.11M | – |
| FY2021 | Dec 31, 2021 | -£6.33M | – |
| FY2020 | Dec 31, 2020 | -£9.51M | – |
| FY2019 | Dec 31, 2019 | -£6.80M | – |
| FY2018 | Dec 31, 2018 | -£13.69M | – |
| FY2017 | Dec 31, 2017 | -£13.66M | – |
| FY2016 | Dec 31, 2016 | -£14.43M | – |
| FY2015 | Dec 31, 2015 | -£13.34M | – |
See a number that looks wrong?